Cargando…

Experience with subcutaneous immunoglobulin therapy in two pediatric cases of immune thrombocytopenia purpura

Detalles Bibliográficos
Autores principales:	Chapdelaine, H, Decaluwe, H, Levasseur, MC, De Deist, F, Haddad, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3487881/ http://dx.doi.org/10.1186/1710-1492-8-S1-A23

Ejemplares similares

Improved quality of life with home therapy with subcutaneous immunoglobulins for patients with secondary hypogammaglobulinaemia
por: Levasseur, Marie-Claude, et al.
Publicado: (2012)

Treatment costs associated with hospital-based intravenous immunoglobulin therapy compared to home-based subcutaneous immunoglobulin therapy in a cohort of paediatric patients with primary immunodeficiency
por: Ducruet, Thierry, et al.
Publicado: (2011)

SCIg vs. IVIg: let’s give patients the choice!
por: Samaan, Kathryn K, et al.
Publicado: (2014)

Economic benefit of subcutaneous rapid push versus intravenous immunoglobulin infusion therapy in adult patients with primary immune deficiency
por: Martin, Adriana, et al.
Publicado: (2012)

Update on chronic immune thrombocytopenic purpura (ITP)
por: McMillan, Robert
Publicado: (2009)

Basic and clinical immunology – 3030. Subcutaneous immunoglobulin therapy: An option for patients who have experienced thrombotic complications with intravenous therapy
por: Moss, Leslie Anne, et al.
Publicado: (2013)

Evaluation of safety and efficacy of a 20% Subcutaneous Immunoglobulin (Hizentra™), after a dose equivalent switch from intravenous or subcutaneous replacement therapy in a cohort of primary immunodeficient patients
por: Martin, Adriana, et al.
Publicado: (2012)

Implications to payers of switch from hospital-based intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy in patients with primary immunodeficiencies (PID) and secondary immunodeficiencies (SID) in Canada
por: Gerth, William C, et al.
Publicado: (2014)

A pilot study of quality of life, mood, sleepiness and fatigue in patients with primary humoral immunodeficiency transitioning to subcutaneous immunoglobulin therapy
por: Pourshahnazari, Persia, et al.
Publicado: (2014)

Immune Thrombocytopenia Purpura Secondary to COVID-19
por: Bennett, Joseph, et al.
Publicado: (2020)

Thrombocytopenic purpura associated with common variable immunodeficiency and bronchiectasis
por: Souza, Thais Martins
Publicado: (2015)

A prospective study of thrombocytopenia and prognosis in intensive care
por: De Weerdt, A, et al.
Publicado: (1999)

Functional common gamma chain is not required for mast cell proliferation and survival
por: Chapdelaine, H, et al.
Publicado: (2012)

IMMUNE THROMBOCYTOPENIA PURPURA ASSOCIATED WITH NOVEL CORONAVIRUS INFECTION
por: Camelo, R.M., et al.
Publicado: (2020)

Tozinameran: Immune thrombocytopenia purpura flare: case report
Publicado: (2022)

P03-009 - Experiences of in pediatric Behçet uveitis
por: Sozeri, B, et al.
Publicado: (2013)

Is It Safe to Switch From Intravenous Immunoglobulin to Subcutaneous Immunoglobulin in Patients With Common Variable Immunodeficiency and Autoimmune Thrombocytopenia?
por: Scheuerlein, Philipp, et al.
Publicado: (2018)

Newly developed thrombocytopenia in medical intensive care patients
por: Strauss, R, et al.
Publicado: (2000)

Evaluation of thrombocytopenia in a general intensive care unit
por: Youssef, NCM, et al.
Publicado: (2001)

Severe ceftazidime-induced drug reaction with eosinophilia and systemic symptoms (DRESS)
por: Picard, Matthieu, et al.
Publicado: (2011)

Immune thrombocytopenia purpura flare post COVID-19 vaccine
por: Ali, Elrazi, et al.
Publicado: (2021)

Safety of specific subcutaneous immunotherapy in patients with allergic rhinitis
por: Da Fonseca, Mario Henrique Almeida, et al.
Publicado: (2015)

Treatment of adults with sepsis-induced coagulopathy and purpura fulminans with a plasma-derived protein C concentrate (Ceprotin)(®)
por: Schellongowski, P, et al.
Publicado: (2003)

Ventricular Tachycardia in a Pediatric Patient with High-Risk Thrombotic Thrombocytopenia Purpura
por: Kratochvil, Taylor J., et al.
Publicado: (2023)

Experience with early commencement of immunoglobulin treatment in score-identified high risk septic patients postoperatively after congenital heart surgery
por: Makhija, Zeena, et al.
Publicado: (2015)

Longitudinal Characteristics of Anti-Platelet Factor 4 Immunoglobulin G in Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Huynh, Angela, et al.
Publicado: (2022)

Measured depth of subcutaneous tissue on posterolateral arm of omalizumab patients
por: Potts, Ryan, et al.
Publicado: (2012)

Multiple Intestinal Atresia With Combined Immune Deficiency Related to TTC7A Defect Is a Multiorgan Pathology: Study of a French-Canadian-Based Cohort
por: Fernandez, Isabel, et al.
Publicado: (2014)

IMMUNE THROMBOCYTOPENIA PURPURA FLARE POST SARS-COV-2 VACCINATION
por: Ali, Elrazi, et al.
Publicado: (2021)

Administration and burden of subcutaneous immunotherapy for allergic rhinitis in clinical practice in Canada
por: Blume, Steven W, et al.
Publicado: (2014)

Measured depth of subcutaneous tissue on posterolateral arm of aeroallergen immunotherapy patients
por: Kim, Laura, et al.
Publicado: (2012)

Subcutaneous allergen immunotherapy with dermatophagoides pteronyssinus in patient with local allergic rhinitis
por: Rondon, Carmen, et al.
Publicado: (2015)

Unusual presentation of a patient with complement deficiency and immunoglobulin deficiency
por: Manga, Vaishaali, et al.
Publicado: (2014)

Assessment of food specific immunoglobulin load in pre-school children
por: Jathar, Vithal
Publicado: (2015)

Cerebral Venous Thrombosis after Intravenous Immunoglobulin Therapy in Immune Thrombocytopenic Purpura
por: James, Joe, et al.
Publicado: (2017)

Cerebral Venous Thrombosis after Intravenous Immunoglobulin Therapy in Immune Thrombocytopenic Purpura
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2018)

Prophylactic anticoagulation with low dose enoxaparin: is the subcutaneous route appropriate in the critically ill?
por: Priglinger, U, et al.
Publicado: (2002)

Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Early-onset thrombocytopenia, severe polyarthritis, and severe Β cell impairment in a Down syndrome patient
por: Willy-Fabro, Ana Paula, et al.
Publicado: (2015)

A male infant with eczema and persistent thrombocytopenia, without micro-platelets: an atypical Wiskott-Aldrich syndrome?
por: De Albuquerque, Paula Danielle Santa Maria, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h5gf7qd85gaic7pht6c5dicb5h